Company Filing History:
Years Active: 2003
Title: Kiflai Bein: Innovator in Peptide Inhibitors
Introduction
Kiflai Bein is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biomedical research, particularly in the development of peptide inhibitors.
Latest Patents
Kiflai Bein holds a patent for a "Peptide inhibitor of MMP activity and angiogenesis." This invention focuses on peptides that interact with thrombospondin 2 and inhibit matrix metalloproteinase 9 (MMP-9) activity. The peptides developed through this invention are therapeutic against diseases characterized by neovascularization, such as cancer and arthritis.
Career Highlights
Kiflai Bein is associated with Beth Israel Deaconess Medical Center, Inc., where he continues to advance his research and innovations. His work has the potential to impact the treatment of various diseases regulated by MMP-9.
Collaborations
Kiflai Bein collaborates with Michael Simons, enhancing the research efforts in their field.
Conclusion
Kiflai Bein's innovative work in peptide inhibitors showcases his commitment to advancing medical science and improving therapeutic options for patients.